Short answer
Oscar Health, Inc. (OSCR) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $6M (down 28.5% year over year) with net income of $167M.
Q3 2026 key financials · XBRL
- Revenue
- $6M
- −28.5% YoY · +3.3% QoQ
- Net income
- $167M
- +221.7% YoY · −53.8% QoQ
- Operating margin
- 2827.9%
- EPS (diluted)
- $0.43
- +182.7% YoY · −60.6% QoQ
Source: XBRL data from the Oscar Health, Inc. (OSCR) Q3 2026 10-Q on SEC EDGAR. USD.
Oscar Health, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $5.14B, up 72% YoY from $2.99B, driven by rate increases and higher membership
- MLR 84.0% vs 88.5% YoY, SG&A ratio 14.0% vs 17.5%
- Individual and Small Group membership 2.69M vs 2.11M, up 27% YoY
- Operating cash flow $3.5B for nine months vs $423.0M YoY, investment purchases drove $1.8B investing outflow
- eAPTC expiration and enrollment-integrity rules threaten membership, with tariffs risking higher medical costs and MLR
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Carried-forward regulatory risk: compliance obligations under health insurance laws
- Carried-forward market risk: competition affecting membership growth and pricing
- Carried-forward financial risk: operating losses and capital requirements affecting liquidity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Oscar Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.